These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35546761)

  • 21. Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.
    Atabati H; Yazdanpanah E; Mortazavi H; Bajestani SG; Raoofi A; Esmaeili SA; Khaledi A; Saburi E; Afshari JT; Sathyapalan T; Moghaddam AS; Sahebkar A
    Adv Exp Med Biol; 2021; 1286():87-105. PubMed ID: 33725347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.
    Samanta S
    Anticancer Agents Med Chem; 2022; 22(4):605-628. PubMed ID: 33305713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal cancers: influence of gut microbiota, probiotics and prebiotics.
    Serban DE
    Cancer Lett; 2014 Apr; 345(2):258-70. PubMed ID: 23981580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular and molecular effects of yeast probiotics on cancer.
    Saber A; Alipour B; Faghfoori Z; Yari Khosroushahi A
    Crit Rev Microbiol; 2017 Feb; 43(1):96-115. PubMed ID: 27561003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of gut microbiota in tumorigenesis and treatment.
    Xu JY; Liu MT; Tao T; Zhu X; Fei FQ
    Biomed Pharmacother; 2021 Jun; 138():111444. PubMed ID: 33662679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the bioactivity of peptides from probiotics.
    Mandal SM; Pati BR; Chakraborty R; Franco OL
    Front Biosci (Elite Ed); 2016 Jun; 8(3):450-9. PubMed ID: 27100351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota Modulation in the Context of Immune-Related Aspects of
    Kaźmierczak-Siedlecka K; Roviello G; Catalano M; Polom K
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Probiotics in Modulating Human Gut Microbiota Populations and Activities in Patients with Colorectal Cancer-A Systematic Review of Clinical Trials.
    Wierzbicka A; Mańkowska-Wierzbicka D; Mardas M; Stelmach-Mardas M
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33915854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary Additive Probiotics Modulation of the Intestinal Microbiota.
    Hu S; Wang L; Jiang Z
    Protein Pept Lett; 2017; 24(5):382-387. PubMed ID: 28240160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psoriasis: Interplay between dysbiosis and host immune system.
    Kapoor B; Gulati M; Rani P; Gupta R
    Autoimmun Rev; 2022 Nov; 21(11):103169. PubMed ID: 35964945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of gut microbiome on bone health and related dietary strategies against bone dysfunctions.
    Peng J; Yu XJ; Yu LL; Tian FW; Zhao JX; Zhang H; Chen W; Zhai QX
    Food Res Int; 2021 Jun; 144():110331. PubMed ID: 34053534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
    Smet A; Kupcinskas J; Link A; Hold GL; Bornschein J
    Cell Mol Gastroenterol Hepatol; 2022; 13(3):857-874. PubMed ID: 34506954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host immune interactions in chronic inflammatory gastrointestinal conditions.
    Caminero A; Pinto-Sanchez MI
    Curr Opin Gastroenterol; 2020 Nov; 36(6):479-484. PubMed ID: 32868507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics and Probiotic-Derived Functional Factors-Mechanistic Insights Into Applications for Intestinal Homeostasis.
    Yan F; Polk DB
    Front Immunol; 2020; 11():1428. PubMed ID: 32719681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers.
    Singh D; Khan MA; Siddique HR
    Life Sci; 2021 Nov; 285():120008. PubMed ID: 34606851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.
    Heidari Z; Tajbakhsh A; Gheibihayat SM; Moattari A; Razban V; Berenjian A; Savardashtaki A; Negahdaripour M
    Recent Pat Biotechnol; 2021 Oct; 15(2):112-136. PubMed ID: 33874878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics.
    Yang H; Liu Y; Cai R; Li Y; Gu B
    Ann Palliat Med; 2021 Feb; 10(2):2304-2313. PubMed ID: 33549028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.